Search
Influenza B virus B/Austria/1359417/2021 recombinant hemagglutinin antigen
go.drugbank.com/drugs/DB16923ApprovedA seasonally-specific component of the influenza vaccine. The influenza vaccine, also known as the "flu shot", is a vaccine that helps to protect against infection from influenza viruses. … Inactivated vaccines contain a virus particle that has been grown in media and then subsequently killed, or inactivated, through exposure to heat or chemicals such as formaldehyde.
PR006
go.drugbank.com/drugs/DB17002ExperimentalPR006 is a non-replicating recombinant adeno-associated virus serotype 9 containing the progranulin gene. It is being investigated for the treatment of dementia.
IMCY-0141
go.drugbank.com/drugs/DB17019InvestigationalIMCY-0141 is a synthetic peptide based on MOG (Myelin Oligodendrocyte Glycoprotein), a dominant autoantigen, designed to stop the progression of multiple sclerosis (MS) and the destruction of the myelin
NSC-663284
go.drugbank.com/drugs/DB17038ExperimentalNSC-663284 is a potent quinolinedione Cdc25 phosphatase inhibitor.[A253052]
PIK-75
go.drugbank.com/drugs/DB17047ExperimentalPIK-75 is a preferential p110 alpha/gamma PI3K inhibitor.[A253097]
Synonyms: Benzenesulfonic acid, 2-methyl-5-nitro-, 2-((6-bromoimidazo(1,2-a)pyridin-3-yl)methylene)-1-methylhydrazidePlumbagin
go.drugbank.com/drugs/DB17048InvestigationalPlumbagin is a compound investigated for its anticancer activity. It has been found that it inactivates the Akt/NF-kB, MMP-9 and VEGF pathways.[A253102]
Categories: Compounds used in a research, industrial, or household settingRS-39604
go.drugbank.com/drugs/DB17050ExperimentalRS-39604 is a selective 5-HT4 receptor antagonist.[A253112]
SB-218078
go.drugbank.com/drugs/DB17051ExperimentalSB-218078 is a specific inhibitor of CHK1.[A253117]
Scriptaid
go.drugbank.com/drugs/DB17053ExperimentalScriptaid is a histone deacetylase (HDAC) inhibitor researched for its anti-tumor properties.[A253127]
SKF-96365 free base
go.drugbank.com/drugs/DB17054ExperimentalSKF-96365 is a receptor-mediated calcium entry (RMCE) inhibitor structurally different from other calcium antagonists.[A253132]